Diploma (LON:DPLM) Shares Up 0.4% – Here’s What Happened

Diploma PLC (LON:DPLM) shares traded up 0.4% on Wednesday . The stock traded as high as GBX 4,878 ($65.33) and last traded at GBX 4,878 ($65.33). 11,769,962 shares were traded during trading, an increase of 1,964% from the average session volume of 570,198 shares. The stock had previously closed at GBX 4,860 ($65.09).

Diploma Price Performance

The business’s fifty day moving average is GBX 3,949.28 and its 200-day moving average is GBX 4,253.28. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The firm has a market cap of £6.50 billion, a PE ratio of 56.05, a P/E/G ratio of 2.82 and a beta of 0.75.

Diploma (LON:DPLM) last released its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.07) earnings per share for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. On average, research analysts predict that Diploma PLC will post 163.7995512 earnings per share for the current fiscal year.

Insider Activity at Diploma

In other Diploma news, insider David S. Lowden purchased 750 shares of the company’s stock in a transaction dated Friday, March 21st. The stock was purchased at an average price of GBX 3,928 ($52.60) per share, for a total transaction of £29,460 ($39,453.60). Also, insider Ian El-Mokadem acquired 500 shares of the business’s stock in a transaction dated Monday, March 24th. The shares were acquired at an average cost of GBX 3,948 ($52.87) per share, with a total value of £19,740 ($26,436.32). 0.52% of the stock is currently owned by company insiders.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.